— Know what they know.
Not Investment Advice
Also trades as: ASG.V (TSXV) · $vol 0M

ASAPF OTC

Aurora Spine Corporation
1W: +8.7% 1M: -31.5% 3M: -44.2% YTD: -49.7% 1Y: -51.2% 3Y: -49.3% 5Y: -81.2%
$0.10
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 40 · $7.6M mcap · 59M float · 0.034% daily turnover · Short 59% of daily vol

Cash Flow Trends

Operating Cash Flow
$904K +196.7% ▲
5Y CAGR: +315.6%
Capital Expenditures
$409K +14.7% ▲
5Y CAGR: +7.3%
Free Cash Flow
$496K +135.1% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$59K -82.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$232K-$2M-$2M-$2M-$954K
Depreciation & Amort.$590K$649K$869K$1M$959K
Stock-Based Comp.$93K$141K$142K$135K$0
Change in Working Capital$96K-$744K-$1M-$828K$593K
Other Non-Cash Items-$486K$144K$292K$389K$306K
Operating Cash Flow$310K-$2M-$2M-$935K$904K
— Investing Activities —
Capital Expenditures-$555K-$721K-$873K-$479K-$607K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$45K$0-$102K$0$123K
Investing Cash Flow-$555K-$721K-$873K-$479K-$484K
— Financing Activities —
Net Debt Issuance-$142K-$208K-$416K-$317K-$361K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$51K-$788K$97K$664K$0
Financing Cash Flow$2M$4M-$318K$2M-$361K
Net Change in Cash$1M$1M-$3M$343K$59K
Cash End of Period$2M$3M$423K$767K$825K
Free Cash Flow-$245K-$3M-$2M-$1M$496K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms